Viewing StudyNCT04697069



Ignite Creation Date: 2024-05-06 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04697069
Status: TERMINATED
Last Update Posted: 2023-01-09
First Post: 2020-12-23

Brief Title: A Study to Evaluate of the Efficacy and Safety of Imsidolimab ANB019 in the Treatment of Acneiform Rash
Sponsor: AnaptysBio Inc
Organization: AnaptysBio Inc

Conditions & Keywords Data

Conditions:
Name
Acneiform Eruptions
Keywords:
Name View
IL-36 receptor View
Interleukin 36 View
Imsidolimab View